These findings suggested that the inactivation of NF-κB could contribute to IL-32γ-induced tumor growth inhibition through blockade of skin inflammation and cancer cell sphere formation with the downregulation of ITGAV and TIMP-1. The gene discussed is TIMP1; the disease is neoplasm.